Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2026-01-01 @ 9:49 AM
Study NCT ID:
NCT05516758
Status:
TERMINATED
Last Update Posted:
2025-12-04
First Post:
2022-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-24
First Submit QC Date:
None
Study First Post Date:
2022-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-20
Results First Submit QC Date:
None
Results First Post Date:
2025-12-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-03-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-12-04
Last Update Post Date Type:
ESTIMATED